(1H, d, J 2.3), 4.11 (1H, d, J 2.3), 4.20–4.25 (2H, m), 4.28 (1H,
d, J 2.0), 4.52 (1H, s), 6.49 (1H, m, NH), 7.45–7.51 (3H, m) and
7.78–7.84 (2H, m); m/z 448 (Mϩ, 12%), 219 (72), 172 (25), 134
(9), 105 (100), 98 (26), 84 (19), 77 (22), 70 (9), 59 (23), 48 (40)
and 43 (29) (Found: Mϩ, 448.2203. C23H32N2O7 requires M,
448.2209) and (ii) the (3R,5S)-isoxazolidine 7d (159 mg, 14%),
Rf 0.31 (EtOAc–hexane–Et3N, 1:2:0.1), as a colourless glass,
νmax/cmϪ1 3550 and 1640; δH (250) 1.35 (3H, s), 1.42 (6H, s,
2 × Me), 1.49 (3H, s), 2.17 (1H, m, 4-Ha), 2.69 (1H, ddd, J 12.5,
6.1 and 2.6, 4-Hb), 2.85 (3H, s, NMe), 3.22 (1H, dd, J 9.4 and
2.6, 3-H), 3.52 (1H, ddd, J 14.0, 5.6 and 3.5, CHaNH), 3.85
(1H, ddd, J 14.0, 6.1 and 3.5, CHbNH), 4.06 (1H, s), 4.18–4.24
(2H, m), 4.27 (1H, d, J 2.0), 4.37 (1H, s), 4.38 (1H, s), 6.47 (1H,
t, J 3.5, NH), 7.43–7.51 (3H, m) and 7.77–7.80 (2H, m); m/z 448
(Mϩ, 20%), 219 (89), 172 (24), 134 (6), 105 (100), 98 (18),
84 (11), 77 (22), 70 (12), 59 (11), 48 (14) and 43 (24) (Found:
Mϩ, 448.2211).
(11), 136 (13), 126 (6), 115 (22), 83 (14), 74 (100), 69 (23), 58
(68), 43 (42) and 30 (20) (Found: Mϩ, 344.1945. C16H28N2O6
requires M, 344.1947) and (ii) the cis-1,2,5-oxadiazinane 13a
(62 mg, 10%), Rf 0.14, as a colourless solid, mp 83 ЊC (Found:
C, 55.6; H, 8.5; N, 7.8%) [α]D20 Ϫ65.5 (c 0.49, CHCl3); νmax/cmϪ1
3320; δH (250) 1.13 and 1.17 (3H, d, J 6.3, 3-Me), 1.38 (3H, s),
1.40 (3H, s), 1.43 (3H, s), 1.45 (3H, s), 2.38 (1H, br s, NH), 2.56
and 2.57 (3H, s, 2-Me), 2.67 (1H, m, 4-Hax), 2.75 (1H, br, 3-H),
2.81 (1H, dd, J 13.7 and 4.8, 4-Heq), 4.05–4.14 (3H, m), 4.26
(1H, m), 4.61 (1H, s) and 4.74 (1H, s, 6-H); m/z 344 (Mϩ, 47%),
329 (8), 256 (10), 155 (16), 136 (17), 115 (32), 74 (100), 69 (29)
and 58 (52) (Found: Mϩ, 344.1924).
(؉)-trans- and (؊)-cis-2-Benzyl-6-(2-deoxy-3,5-O-isopropyl-
idene-1,2-isopropylidenedioxy-ꢁ-L-xylo-furanosyl)-3-methyl-
1,2,5-oxadiazinane 12b and 13b
A solution of allylamine 11 (0.270 g, 5.17 mmol) and the N-
benzyl nitrone 1b (1.88 g, 5.17 mmol) in toluene (30 ml) was
refluxed for 10 h then, was cooled and evaporated. CC (EtOAc–
hexane–Et3N, 1:1:0.1) of the residue separated (i) the trans-
1,2,5-oxadiazinane 12b (1.23 g, 56%), Rf 0.45, as a colourless
solid, mp 98 ЊC (from ether–LP) (Found: C, 62.8; H, 7.7; N, 6.7.
C22H32N2O6 requires C, 62.8; H, 7.7; N, 6.7%), [α]D20 ϩ74 (c 1,
CHCl3); νmax/cmϪ1 3300; δH (250) 1.02 (3H, d, J 5.7, 3-Me), 1.31
(3H, s), 1.40 (3H, s), 1.41 (3H, s), 1.42 (3H, s), 2.82 (1H, ddq,
J 8.7, 8.7 and 5.7, 3-H), 2.83 (1H, dd, J 8.7 and 8.7, 4-Hax), 3.00
(1H, app. d, J 8.7, 4-Heq), 3.69 (1H, d, J 14.7, PhCHa), 3.86 (1H,
d, J 14.7, PhCHb), 4.03 (1H, d, J 2.8), 4.05 (1H, d, J 1.9), 4.14
(1H, d, J 1.9), 4.16-4.19 (1H, m), 4.53 (1H, s), 4.73 (1H, s, 6-H),
7.23–7.32 (3H, m) and 7.38–7.45 (2H, m); δC (67.8) 15.9 (3-Me),
18.6, 26.3, 27.3, 28.8 [all MeC(O)O], 51.0 (4-CH2), 58.8
(5Ј-CH2), 59.5 (3-CH), 59.9 (PhCH2), 72.5, 72.9, 84.9 (all
CHO), 89.0 (6-CH), 97.1, 112.2, 112.6 (all C), 126.4, 127.8,
128.2 (all Ph CH) and 138.0 (Ph C); m/z 420 (Mϩ, 9%), 175 (20),
150 (29), 134 (12), 91 (100) and 59 (15) (Found: Mϩ, 420.2258.
C22H32N2O6 requires M, 420.2260) and (ii) the cis-1,2,5-
oxadiazinane 13b (420 mg, 19%), Rf 0.58, as a colourless glass
(Found: C, 62.4; H, 7.8; N, 6.3%) [α]D20 Ϫ30.8 (c 1.01, CHCl3);
νmax/cmϪ1 3340; δH (250) 1.00 (3H, d, J 6.9, 3-Me), 1.38 (3H, s),
1.42 (9H, s), 2.82 (1H, dqd, J 10.1, 6.9 and 2.6, 3-H), 2.85 (1H,
dd, J 13.1 and 10.1, 4-Hax), 3.01 (1H, dd, J 13.1 and 2.6, 4-Heq),
4.02–4.11 (4H, m), 4.21 (1H, d, J 13.1, PhCHa), 4.23 (1H, d,
J 13.1, PhCHb), 4.50 (1H, s), 4.90 (1H, s, 6-H), 7.25–7.32 (3H,
m) and 7.41–7.45 (2H, m); δC (67.8) 15.9 (3-Me), 18.7, 26.0,
27.4, 28.6 [all MeC(O)O], 50.8 (4-CH2), 59.2 (5Ј-CH2), 59.8
(3-CH), 60.1 (PhCH2), 72.3, 72.9, 84.7 (all CHO), 88.4 (6-CH),
97.3, 112.4, 113.2 (all C), 127.7, 128.1, 128.2 (all Ph CH) and
138.1 (Ph C); m/z 420 (Mϩ, 14%), 175 (9), 150 (90), 134 (10)
and 91 (100) (Found: Mϩ, 420.2246).
(3RS,5RS)- and (3RS,5SR)-5-Benzoylaminomethyl-2-methyl-3-
phenylisoxazolidine 9 and 10
A solution of N-2-propen-1-ylbenzamide 6b (1.20 g, 7.40
mmol) and the benzaldehyde-derived nitrone 8 (1.00 g, 7.40
mmol) in toluene (40 ml) was refluxed for 192 h, then cooled
and evaporated. CC (EtOAc–LP, 1:1] of the residue separated
(i) the (3RS,5RS)-trans-isoxazolidine 9 (770 mg, 35%), Rf 0.27,
as a colourless solid, mp 99–100 ЊC (Found: C, 72.9; H, 7.1;
N, 9.4. C18H20N2O2 requires C, 72.9; H, 6.8; N, 9.5%), νmax/cmϪ1
3330 and 1635; δH (250) 2.15 (1H, ddd, J 12.7, 8.0 and 5.6,
4-Ha), 2.60 (3H, s, 2-Me), 2.83 (1H, ddd, J 12.7, 8.0 and 8.0,
4-Hb), 3.56 (1H, dd, J 8.0 and 8.0, 3-H), 3.69 (1H, ddd, J 13.9,
3.7 and 3.7, CHaNH), 3.74 (1H, ddd, J 13.9, 5.3 and 3.7,
CHbNH), 4.47 (1H, m, 5-H), 7.21–7.29 (5H, m), 7.40–7.45 (3H,
m) and 7.78–7.83 (2H, m); δC (67.8) 42.4 (4-CH2), 43.0 (2-Me),
44.5 (1Ј-CH2), 73.5 (3-CH), 75.0 (5-CH), 127.0, 127.5, 128.0,
128.5, 128.7 (Ph CH), 131.4, 138.4 (Ph C) and 167.6 (CO);
m/z 296 (Mϩ, 33%), 251 (14), 160 (39), 147 (41), 120 (76), 106
(23), 105 (100), 91 (16) and 77 (98) (Found: Mϩ, 296.1512.
C18H20N2O2 requires M, 296.1525) and ii) the (3RS,5SR)-cis-
isoxazolidine 10 (250 mg, 11%), Rf 0.17, as a colourless solid,
mp 83–85 ЊC (Found: C, 72.8; H, 6.8; N, 9.3), νmax/cmϪ1 3307
and 1641; δH (250) 2.38–2.44 (2H, m, 4-CH2), 2.58 (3H, s,
2-Me), 3.44–3.50 (1H, m, 3-H), 3.61 (1H, ddd, J 13.0, 5.9 and
5.9, CHaNH), 3.74 (1H, ddd, J 13.0, 5.9 and 3.6, CHbNH),
4.44–4.49 (1H, m, 5-H), 6.93 (1H, br res, NH), 7.32–7.42 (8H,
m) and 7.78–7.83 (2H, m); δC (67.8) 42.2 (4-CH2), 42.7 (2-Me),
43.1 (1Ј-CH2), 73.1 (3-CH), 75.7 (5-CH), 126.9, 127.5, 127.8,
128.5, 128.7 (Ph CH), 131.3, 138.6 (Ph C) and 167.6 (CO);
m/z 296 (Mϩ, 3%), 147 (11), 120 (12), 106 (9), 105 (100), 91 (8)
and 77 (46) (Found: Mϩ, 296.1526).
(؉)-trans- and (؊)-cis-6-(2-deoxy-3,5,-O-isopropylidene-1,2-
isopropylidenedioxy-ꢁ-L-xylo-furanosyl)-2,3-dimethyl-1,2,5-
oxadiazinane 12a and 13a
trans-2,3-Dimethyl-6-phenyl-1,2,5-oxadiazinane 24
(i) A solution of the nitrone 8 (100 mg, 0.74 mmol) and
allylamine 11 (42 mg, 0.74 mmol) in deuteriochloroform (1 ml)
was stirred at ambient temperature for 7 days (NMR monitor-
ing), then evaporated to leave the oxadiazinane 24 (142 mg,
100%) as a pale yellow oil which exhibited spectral data identi-
cal to the sample described below in (iii) and which was pure
according to NMR analysis (see below).
(ii) A solution of the nitrone 8 (100 mg, 0.74 mmol) and
allylamine 11 (42 mg, 0.74 mmol) in deuteriochloroform (1 ml)
was stirred at 45 ЊC for 36 h (NMR monitoring), then evapor-
ated to leave the oxadiazinane 24 (142 mg, 100%) as a pale
yellow oil which exhibited spectral data identical to the sample
below and which was pure according to NMR analysis (see
below).
A solution of allylamine 11 (0.198 g, 3.48 mmol) and the
N-methyl nitrone 1a (0.318 g, 1.74 mmol) in toluene (30 ml) was
refluxed for 10 h, then was cooled and evaporated. CC (EtOAc–
hexane–Et3N, 1:1:0.1) of the residue separated (i) the trans-
1,2,5-oxadiazinane 12a (213 mg, 36%), Rf 0.20, as a colourless
solid, mp 71 ЊC (from ether–LP) (Found: C, 55.6; H, 8.4; N, 7.8.
C16H28N2O6 requires C, 55.8; H, 8.2; N, 8.1%) [α]D20 ϩ10.4 (c 1.06,
CHCl3); νmax/cmϪ1 3320; δH (250) 0.88 (3H, d, J 6.3, 3-Me), 1.31
(3H, s), 1.33 (3H, s), 1.36 (3H, s), 1.41 (3H, s), 2.41 (1H, dqd,
J 10.6, 6.3 and 3.0, 3-H), 2.60 (3H, s, 2-Me), 2.67 (1H, dd, J 13.7
and 10.6, 4-Hax), 2.89 (1H, dd, J 13.7 and 3.0, 4-Heq), 3.98 (1H,
d, J 2.2), 4.01 (2H, app. d, J 2.5), 4.18 (1H, d, J 2.2), 4.52 (1H, s)
and 4.66 (1H, s, 6-H); δC (67.8) 15.4 (3-Me), 18.4, 26.2, 27.1,
28.6 [all MeC(O)O], 43.5 (2-Me), 50.2 (4-CH2), 59.6 (6Ј-CH2),
61.6 (3-CH), 72.1, 73.1, 85.2 (all CHO), 88.9 (6-CH), 97.1,
112.0 and 112.5 (all C); m/z 344 (Mϩ, 18%), 183 (7), 171 (8), 155
(iii) A solution of the benzaldehyde nitrone 8 (1.0 g, 7.4
mmol) and allylamine 11 (0.55 ml, 7.4 mmol) in toluene (30 ml)
was refluxed for 17 h, then cooled and evaporated. CC (EtOAc–
hexane, 1:2) of the residue gave the oxadiazinane 24 (1.14 g,
3300
J. Chem. Soc., Perkin Trans. 1, 2000, 3292–3305